Skip to main content

Greenwich LifeSciences, Inc.

GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001799788

In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Greenwich LifeSciences, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of GLSI: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders5150−1
Shares1.21M1.33M+112.9K (+9.3%)
Value$12.1M$27.9M+$15.8M (+130.8%)

New holders (7)

Institutions that held Greenwich LifeSciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to GLSI in Q4 2025
InstitutionSharesValue% of portfolio
Credit Agricole S A87,000$1.83M0.01%
Virtu Financial LLC28,797$605.0K0.02%
Man Group plc28,068$589.7K0.00%
XTX Topco Ltd10,325$216.9K0.01%
Jane Street Group, LLC9,677$203.3K0.00%
Farther Finance Advisors, LLC919$19.3K0.00%
UBS Asset Management Americas Inc193$4.05K0.00%

Sold out (8)

Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of GLSI in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Renaissance Technologies LLC38,400$382.1K
Marshall Wace, LLP32,051$318.9K
Millennium Management LLC15,498$154.2K
SRS Capital Advisors, Inc.123$1.22K
Hopwood Financial Services, Inc.50$498
Global Retirement Partners, LLC45$448
SBI Securities Co., Ltd.30$299
Nisa Investment Advisors, LLC27$269